News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,067 Results
Type
Article (19459)
Company Profile (25)
Press Release (276583)
Section
Business (77665)
Career Advice (654)
Deals (13372)
Drug Delivery (39)
Drug Development (50690)
Employer Resources (40)
FDA (9208)
Job Trends (6389)
News (151738)
Policy (15505)
Tag
2024 BioMidwest Digital (1)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (3)
2024 Pharm Country Standard (2)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
Academia (1586)
Accelerated approval (1)
Adcomms (13)
Allergies (40)
Alliances (18266)
ALS (58)
Alzheimer's disease (953)
Antibody-drug conjugate (ADC) (56)
Approvals (9257)
Artificial intelligence (86)
Autoimmune disease (6)
Automation (7)
Bankruptcy (133)
Best Places to Work (5672)
BIOSECURE Act (5)
Biosimilars (44)
Biotechnology (20)
Bladder cancer (47)
Brain cancer (15)
Breast cancer (150)
Cancer (1182)
Cardiovascular disease (106)
Career advice (538)
Career pathing (14)
CAR-T (99)
Cell therapy (239)
Cervical cancer (9)
Clinical research (41465)
Collaboration (334)
Compensation (142)
Complete response letters (9)
COVID-19 (1290)
CRISPR (23)
C-suite (77)
Cystic fibrosis (56)
Data (1391)
Decentralized trials (1)
Denatured (2)
Depression (12)
Diabetes (148)
Diagnostics (2853)
Digital health (7)
Diversity (2)
Diversity, equity & inclusion (15)
Drug discovery (53)
Drug pricing (33)
Drug shortages (17)
Duchenne muscular dystrophy (54)
Earnings (34711)
Editorial (12)
Employer branding (4)
Employer resources (38)
Events (43763)
Executive appointments (245)
FDA (9864)
Featured Employer (9)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (289)
Gene editing (58)
Generative AI (9)
Gene therapy (200)
GLP-1 (396)
Government (2258)
Grass and pollen (1)
Guidances (25)
Healthcare (9219)
Huntington's disease (11)
IgA nephropathy (17)
Immunology and inflammation (42)
Indications (21)
Infectious disease (1362)
Inflammatory bowel disease (72)
Inflation Reduction Act (2)
Influenza (21)
Intellectual property (44)
Interviews (90)
IPO (6785)
IRA (13)
Job creations (989)
Job search strategy (493)
Kidney cancer (7)
Labor market (7)
Layoffs (173)
Leadership (6)
Legal (2365)
Liver cancer (37)
Lung cancer (171)
Lymphoma (103)
Machine learning (1)
Management (14)
Manufacturing (106)
MASH (65)
Medical device (5671)
Medtech (5672)
Mergers & acquisitions (6761)
Metabolic disorders (377)
Multiple sclerosis (40)
NASH (19)
Neurodegenerative disease (51)
Neuropsychiatric disorders (9)
Neuroscience (1225)
NextGen: Class of 2025 (2528)
Non-profit (2042)
Northern California (1297)
Now hiring (28)
Obesity (184)
Opinion (84)
Ovarian cancer (35)
Pain (52)
Pancreatic cancer (37)
Parkinson's disease (67)
Partnered (5)
Patents (98)
Patient recruitment (59)
Peanut (22)
People (21587)
Pharmaceutical (10)
Pharmacy benefit managers (4)
Phase I (12124)
Phase II (18153)
Phase III (14547)
Pipeline (636)
Podcasts (18)
Policy (35)
Postmarket research (1749)
Preclinical (5296)
Press Release (19)
Prostate cancer (56)
Psychedelics (10)
Radiopharmaceuticals (136)
Rare diseases (208)
Real estate (1606)
Recruiting (15)
Regulatory (12022)
Reports (10)
Research institute (1196)
Resumes & cover letters (104)
Rett syndrome (3)
RNA editing (1)
RSV (23)
Schizophrenia (39)
Series A (40)
Series B (30)
Service/supplier (2)
Sickle cell disease (36)
Southern California (1072)
Spinal muscular atrophy (97)
Sponsored (10)
Startups (1307)
Stomach cancer (3)
Supply chain (25)
The Weekly (16)
United States (10052)
Vaccines (327)
Venture capitalists (8)
Webinars (4)
Weight loss (109)
Women's health (12)
Worklife (3)
Date
Today (10)
Last 7 days (349)
Last 30 days (1406)
Last 365 days (17243)
2025 (3822)
2024 (18026)
2023 (20286)
2022 (24873)
2021 (26839)
2020 (24806)
2019 (20874)
2018 (15889)
2017 (15603)
2016 (14248)
2015 (17157)
2014 (12143)
2013 (9412)
2012 (10324)
2011 (10441)
2010 (9333)
Location
Africa (283)
Alabama (16)
Arizona (50)
Arkansas (5)
Asia (16300)
Australia (3061)
California (2759)
Canada (860)
China (258)
Colorado (120)
Connecticut (145)
Delaware (64)
Europe (46443)
Florida (336)
Georgia (97)
Idaho (18)
Illinois (211)
India (14)
Indiana (140)
Iowa (2)
Japan (82)
Kansas (56)
Kentucky (6)
Louisiana (4)
Maine (29)
Maryland (364)
Massachusetts (1841)
Michigan (75)
Minnesota (142)
Missouri (32)
Montana (11)
Nebraska (10)
Nevada (23)
New Hampshire (30)
New Jersey (899)
New Mexico (6)
New York (873)
North Carolina (414)
North Dakota (4)
Northern California (1297)
Ohio (96)
Oregon (18)
Pennsylvania (577)
Puerto Rico (4)
Rhode Island (3)
South America (389)
South Carolina (8)
South Dakota (1)
Southern California (1072)
Tennessee (52)
Texas (371)
Utah (74)
Virginia (59)
Washington D.C. (17)
Washington State (283)
West Virginia (1)
Wisconsin (14)
296,067 Results for "european hematology association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress
Bio-Path Holdings, Inc. announced an upcoming poster presentation at the 2024 European Hematology Association Congress, taking place June 13-16, 2024 in Madrid, Spain.
May 24, 2024
·
4 min read
Drug Development
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
Aptose Biosciences Inc. announced a clinical poster presentation and a preclinical e-poster at the European Hematology Association 2024 Hybrid Congress in Madrid, Spain.
June 14, 2024
·
8 min read
BioMidwest
Halia Therapeutics to Participate at BIO International Convention and The European Hematology Association Hybrid Congress
Halia Therapeutics announced that the company will be participating at the upcoming conferences: BIO International Convention taking place June 3-6 in San Diego and at the European Hematology Association 2024 Hybrid Congress taking place June 13-16 in Madrid, Spain.
May 29, 2024
·
2 min read
Pharm Country
IN8bio Announces Upcoming Presentation at 2024 European Hematology Association Congress
IN8bio, Inc. a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, announced a presentation at the European Hematology Association 2024 Congress, to be held June 13-16 in Madrid, Spain.
May 14, 2024
·
4 min read
Genetown
Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association
Keros Therapeutics, Inc. announced that five abstracts will be presented from the KER-050 program at the 29th Annual Congress of the European Hematology Association, to be held both virtually and in person from June 13 through 16, 2024.
May 14, 2024
·
5 min read
Genetown
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
Disc Medicine, Inc. announced that it will present data from multiple programs in its hematology portfolio at the upcoming European Hematology Association 2024 Congress, which will be held in Madrid Spain on June 13-16, 2024.
May 14, 2024
·
6 min read
Genetown
Sumitomo Pharma Presents New Clinical Data on DSP-5336 at the European Hematology Association 2024 Congress
Sumitomo Pharma America, Inc. (SMPA) today announced the oral presentation of data from the ongoing Phase 1/2 first-in-human study of DSP-5336 in patients with relapsed or refractory acute leukemia at the European Hematology Association (EHA) 2024 Hybrid Congress.
June 14, 2024
·
7 min read
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress
Ryvu Therapeutics (WSE: RVU) will present clinical and preclinical data from RVU120 at the 2024 European Hematology Association Congress (EHA), June 13-16, Madrid, Spain.
May 14, 2024
·
6 min read
Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress
Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, presents clinical and preclinical data from RVU120 at the 2024 European Hematology Association Congress (EHA), June 13-16, Madrid, Spain.
June 14, 2024
·
6 min read
Lone Star Bio
Clinical Data on Salarius Pharmaceuticals’ Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting
Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) today announced that investigators at the University of Texas MD Anderson Cancer Center’s Leukemia department presented clinical data on seclidemstat in patients with MDS and CMML at the 2024 European Hematology Association (EHA) Hybrid Congress.
June 17, 2024
·
7 min read
1 of 29,607
Next
